SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-266748
Filing Date
2021-09-07
Accepted
2021-09-07 17:12:00
Documents
2
Group Members
COLUMN GROUP II GP, LPDAVID GOEDDELPETER SVENNILSON

Document Format Files

Seq Description Document Type Size
1 SC 13D d196199dsc13d.htm SC 13D 90493
2 EX-99.1 d196199dex991.htm EX-99.1 6728
  Complete submission text file 0001193125-21-266748.txt   98920
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 4158652050
COLUMN GROUP II, LP (Filed by) CIK: 0001600420 (see all company filings)

IRS No.: 211417046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Subject) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91982 | Film No.: 211239980
SIC: 2834 Pharmaceutical Preparations